
|Videos|November 22, 2021
Topical oxymetazoline 0.1% and upper lid elevation: An overview with Shane Foster, OD
Author(s)Shane Foster, OD, Brooke Henson, Editor
Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients
Advertisement
Shane Foster, OD discusses highlights from his American Academy of Optometry poster presentation on upper eyelid elevation in acquired ptosis patients with once-daily topical Oxymetazoline 0.1%.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Detecting glaucoma progression based on multiple retinal layers' thickness
2
Dry eye an area of prime interest to ODs and MDs in 2025
3
Refractive surgery for myopia vs presbyopia: Tailoring the approach for the individual
4
Dry eye and macular degeneration: A convergence of aging, inflammation, and telomere biology
5




